News Agency News Aggregator Journalist/Editor Broking House Others
#OpeningBell At 9:00 AM Bears charged up as US stocks sink on weak macro data. The SGX Nifty indicates a weak open for Indian markets. HUL will be reporting its Q3 numbers. Stocks in focus are IndusInd Bank, Eris Lifesciences, Zomato. @sant0nair
👉 Among key earnings today, HUL will be reporting its Q3 numbers. 👉 Stocks in focus are IndusInd Bank, Eris Lifesciences, Zomato. 🔴 Live Now @sant0nair #MarketsWIth
Eris Lifesciences declined 2.93% after the pharma company's consolidated net profit rose marginally to Rs 101.86 crore in Q3 FY23 as against Rs 100.77 crore recorded in Q3 FY22.
CNBC-TV18 Stocks Board | #ErisLifesciences acquires 9 dermatology brands from #Glenmark for Rs 340 cr in the Indian market. Deal is at 3.9x FY22 trailing sales. @ekta_batra gets us all the details
Eris Lifesciences Ltd.: Result is marginally below expectations #NirmalBang #resultupdate #nse #bse #Q3 #quarterlyresults #StockMarkets #stockmarketindia #earnings #earningreview #ErisLifesciences
#India: Pre-Open ✦#GlenmarkPharma agreed with Eris Oaknet Healthcare, a wholly owned subsidiary of Eris Lifesciences, to divest the tail brands from its dermatology segment for India and Nepal territories. The transaction cost is Rs 340.48 crores #StockMarket #nseindia #BSE 3/5
#MarketsWithETNOW | Eris Lifesciences is all set to acquire 9 dermat portfolios from Glenmark Pharma for Rs 340 cr The deal will be funded by borrowings and a closure is expected soon, @Sharad9Dubey details- @ErisLS #StockMarket #StocksToWatch
Glenmark Pharmaceuticals: The drugmaker has sold 9 of its dermatology brands in India and Nepal to Eris Lifesciences Ltd for Rs 340 crore. The 9 trademarks acquired by Eris Lifesciences' arm Eris Oaknet Healthcare Pvt Ltd had sales of Rs 87.3 crore in FY22.
#Glenmark Pharmaceuticals: The pharma company entered into an agreement with Eris Oaknet Healthcare, a wholly owned subsidiary of Eris Lifesciences, to divest the tail brands from its dermatology segment, for India and Nepal territories. The transaction cost is Rs 340.48 crore.
#ERIS Eris Lifesciences RESULT
Eris Lifesciences Ltd reports consolidated net profit of Rs. 101.85 crores in Q3 FY2023 #ErisLifesciences #Q3FY23 #9MFY23 #ResultUpdate
#EarningsWithETNOW | Eris Lifesciences Q3FY23 -Cons PAT at Rs 100.2 cr vs Rs 100.7 cr YoY -Cons revenue from operations at Rs 423 cr vs Rs 332 cr YoY #StockMarket #StocksToWatch
Eris Lifesciences reports Q3 earnings. ▶️Net profit up 1.1% at Rs 101.8 cr Vs Rs 100.7 cr (YoY) ▶️Revenue up 27.4% at Rs 423.2 cr Vs Rs 332.1 cr (YoY) ▶️EBITDA up 12.7% at Rs 137.1 cr Vs Rs 121.6 cr (YoY) ▶️Margin at 32.4% Vs 36.6% (YoY)
#3QWithCNBCTV18 | Eris Lifesciences reports Q3 earnings. ▶️Net profit up 1.1% at Rs 101.8 cr Vs Rs 100.7 cr (YoY) ▶️Revenue up 27.4% at Rs 423.2 cr Vs Rs 332.1 cr (YoY) ▶️EBITDA up 12.7% at Rs 137.1 cr Vs Rs 121.6 cr (YoY) ▶️Margin at 32.4% Vs 36.6% (YoY)
TATA INVESTMENT CORPORATION LIMITED 7.45 PM TATA METALIKS LIMITED : 10.00 PM TV18 BROADCAST LIMITED 4.30 PM ERIS LIFESCIENCES LIMITED 12.30 PM ALL TIMES: INDIA STD TIME , EXPECTED TIME IS BASED ON HISTORIC ANNOUNCEMENTS. IT IS NOT ACTUAL TIME.
#Results on January 17 Bank of India, ICICI Lombard General Insurance Company, ICICI Prudential Life Insurance Company, Delta Corp, Eris Lifesciences, Hathway Cable & Datacom, Mastek, Metro Brands, Network18 Media & Investments, TV18 Broadcast,
#RESULTS #Tomorrow #NiftyWaali -- #VaydaWaali ICICI PRUDENTIAL ICICI LOMBARD DELTA CORP #CashWaali BANK OF INDIA ERIS LIFESCIENCES GULSHAN POLYOLS HATHWAY MASTEK METRO BRANDS NETWORK18 NEWGEN SHALBY TATA INVESTMENT TATAMETALIKS TV18 BROADCAST @CNBC_Awaaz #Q3WithAwaaz
Watch Me In Conversation With Mr Amit Bakshi, Chairman & Managing Director – Eris Lifesciences. On Company Results And Business Outlook @ErisLS #ErisLifesciences #NewsParViews #FirstOnZeeBusiness @ZeeBusiness
#ERIS - Eris Lifesciences, Hammer Candlestick Formation on Weekly chart - TradingView -